If Pfizer buy the IP ( following excellent results of OTC trial?) then this may be an added marketing tool for the sale of Consumer Healthcare, where Pfizer keep the IP patents and licence out.
Viagra may become an OTC in some jurisdictions, again with a licensing agreement. However Pfizer maybe more likely to keep as a
mainstay with growing market share using SL delivery.
The sale of Consumer Healthcare is only under consideration, so will take some time, and maybe no sale will eventuate. I doubt our little trial will affect this either way?!
Pfizer sell down of OTC assets, page-4
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.015(7.32%) |
Mkt cap ! $200.9M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 19.0¢ | $407.7K | 2.054M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 114775 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 21756 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| ALA (ASX) Chart |